United Therapeutics Corp - Company Profile
Powered by 
All the sales intelligence you need on United Therapeutics Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how United Therapeutics Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with United Therapeutics Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
United Therapeutics Corp (United Therapeutics) develops and markets therapeutic products for pulmonary arterial hypertension, cancer, and infectious diseases. A robust portfolio of PAH products, a focus on R&D activities, and a strong distribution network are its strengths, even as limited international footprint could be a cause for concern to the company. United Therapeutics could benefit from the strategic agreements, increasing healthcare expenditure in the us, regulatory approvals and the development of new artificial organs, which could provide growth opportunities to the company. However, legal and patent risks, economic and market fluctuations, and intense competition could pose challenges to its operations and financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer